Effects of a 7-day treatment with a novel, orally active, growth hormone (GH) secretagogue, MK-677, on 24-hour GH profiles, insulin-like growth factor I, and adrenocortical function in normal young men.
Copinschi, G, Van Onderbergen, A, L'Hermite-Balériaux, M, Mendel, C M, Caufriez, A, Leproult, R, Bolognese, J A, De Smet, M, Thorner, M O, Van Cauter, EVolume:
81
Language:
english
Journal:
The Journal of Clinical Endocrinology & Metabolism
DOI:
10.1210/jcem.81.8.8768828
Date:
August, 1996
File:
PDF, 913 KB
english, 1996